Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sabrina I. Ophir
Observed name:
Sabrina Ophir
Institution:
Icahn School of Medicine at Mount Sinai
Observed institution:
Icahn School of Medicine at Mount Sinai
ORCID:
0000-0003-1609-4841
Observed ORCID:
0000-0003-1609-4841
OpenAlex ID:
A5027107063
Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants
2022
·
J. Andrew Duty
, Thomas Kraus
, et al.
·
Med
·
21
Development of broadly neutralizing antibodies targeting the cytomegalovirus subdominant antigen gH
2022
·
Andrea J. Parsons
, Sabrina I. Ophir
, et al.
·
Communications Biology
·
19
PDF
Valspodar limits human cytomegalovirus infection and dissemination
2021
·
Andrea J. Parsons
, Tobias Cohen
, et al.
·
Antiviral Research
·
8
Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirus
2022
·
Andrea J. Parsons
, Sabrina I. Ophir
, et al.
·
Antiviral Research
·
4
PDF
A broadly neutralizing human monoclonal antibody generated from transgenic mice immunized with HCMV particles limits virus infection and proliferation
2024
·
Kristina E. Atanasoff
, Andrea J. Parsons
, et al.
·
Journal of Virology
·
3
PDF
N-arylpyrimidinamine (NAPA) compounds are broadly acting inhibitors of human cytomegalovirus infection and spread
2024
·
Kristina E. Atanasoff
, Sabrina I. Ophir
, et al.
·
Antiviral Research
·
2
The CD46 ectodomain participates in human cytomegalovirus infection of epithelial cells
2023
·
Andrea J. Parsons
, Kathryn R. Stein
, et al.
·
Journal of General Virology
·
1
PDF
Show more works
View as search
Works count:
7
Citation count:
58
H-index:
4
I10-index:
2
Year
Topic
Type